|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
1999-11-3
|
|
pubmed:abstractText |
We studied the effect of Bacille Calmette-Guerin (BCG) vaccine as an immunomodulator in MS. According to the guidelines for clinical trials in MS, a single crossover, MRI-monitored trial was performed in 14 patients with relapsing-remitting MS. After treatment, MRI activity was significantly reduced. No major adverse effects were reported. Adjuvant therapy with BCG vaccine was safe and merits study in MS.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0028-3878
|
|
pubmed:author |
pubmed-author:BastianelloSS,
pubmed-author:ButtinelliCC,
pubmed-author:BuzziM GMG,
pubmed-author:ColonneseCC,
pubmed-author:GiugniEE,
pubmed-author:PozzilliCC,
pubmed-author:RistoriGG,
pubmed-author:RuggieriSS,
pubmed-author:SabatiniUU,
pubmed-author:SalvettiMM,
pubmed-author:ViselliFF
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
22
|
|
pubmed:volume |
53
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1588-9
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10534275-Adjuvants, Immunologic,
pubmed-meshheading:10534275-Adult,
pubmed-meshheading:10534275-BCG Vaccine,
pubmed-meshheading:10534275-Brain,
pubmed-meshheading:10534275-Cross-Over Studies,
pubmed-meshheading:10534275-Female,
pubmed-meshheading:10534275-Humans,
pubmed-meshheading:10534275-Magnetic Resonance Imaging,
pubmed-meshheading:10534275-Male,
pubmed-meshheading:10534275-Multiple Sclerosis,
pubmed-meshheading:10534275-Recurrence,
pubmed-meshheading:10534275-Treatment Outcome
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Use of Bacille Calmette-Guèrin (BCG) in multiple sclerosis.
|
|
pubmed:affiliation |
Department of Neurological Sciences, Università La Sapienza, Rome, Italy.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
